Biological effectiveness of antiproton annihilation

被引：17

作者：

Maggiore, C

Agazaryan, N

Bassler, N

Blackmore, E

Beyer, G

DeMarco, JJ

Doser, M

Gruhn, CR

Holzscheiter, MH

Ichioka, T

Iwamoto, KS

Knudsen, HV

Landua, R

McBride, WH

Moller, SP

Petersen, J

Smathers, JB

Skarsgard, LD

Solberg, TD

Uggerhoj, UI

Withers, HR

Wouters, BG

机构：

[1] PBar Med Inc, Newport Beach, CA 92660 USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[3] Aarhus Univ, DK-8000 Aarhus, Denmark

[4] TRIUMF, Vancouver, BC V6T 2A3, Canada

[5] Ctr Med Univ Geneva, CH-1211 Geneva 4, Switzerland

[6] CERN, CH-1211 Geneva 23, Switzerland

[7] Aarhus Kommune Hosp, DK-8000 Aarhus C, Denmark

[8] British Columbia Canc Res Ctr, Vancouver, BC V5Z 4E6, Canada

[9] Univ Maastricht, Maastricht, Netherlands

来源：

NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS | 2004年 / 214卷

关键词：

antiproton annihilation; Bragg peak; biological response;

D O I：

10.1016/S0168-583X(03)01781-6

中图分类号：

TH7 [仪器、仪表];

学科分类号：

0804 ; 080401 ; 081102 ;

摘要：

A new experiment, AD-4/ACE (antiproton cell experiment), has been approved by the CERN Research Board. The experiment is scheduled to begin taking data in June and continue through the 2003 run cycle. The experiment is designed to determine whether or not the densely ionizing particles emanating from the annihilation of antiprotons produce an increase in "biological dose" in the vicinity of the narrow Bragg peak for antiprotons compared to protons. This experiment is the first direct measurement of the biological effects of antiproton annihilation. The background, description, and status of the experiment are given. (C) 2003 Elsevier B.V. All rights reserved.

引用

页码：181 / 185

页数：5

共 7 条

[1]

*CERN, 2002, CERNSPSC2002040

[2]

*CERN, 2002, CERNSPSC2002030

[3] POSSIBLE BIOMEDICAL APPLICATIONS OF ANTIPROTON BEAMS - FOCUSED RADIATION TRANSFER [J].